METHYS Dx has been selected to join the Paris Saclay Cancer Cluster (PSCC) BOOST program !

19/09/2025 – METHYS Dx has been selected to join the Paris Saclay Cancer Cluster (PSCC) BOOST program. METHYS Dx is delighted to have been selected alongside 8 other innovative start-ups in the field of oncology!

Congratulations to the other selected start-ups sélectionnées  : BiPER Therapeutics,  CYBERNA, 𝗟𝗮𝗳𝗮𝗺𝗲, 𝗡𝗮𝗻𝗼𝗞𝘂𝗿 , Peekcell , 𝗦𝗽𝗶𝗰𝗲 𝗕𝗶𝗼, Syntopia and 𝗧𝗮𝘁𝘂𝗺 𝗕𝗶𝗼𝘀𝗰𝗶𝗲𝗻𝗰𝗲𝘀.

We are very excited to embark on this journey and to benefit from the support of PSCC!